Titlebook: Immunotherapy for Head and Neck Cancer; Anthony T. C. Chan,Brigette B.Y. Ma Book 2023 The Editor(s) (if applicable) and The Author(s), und

reperfusion

胰臟

Immunotherapy in Recurrent and Metastatic Nasopharyngeal Carcinoma,y to the successful development of immune checkpoint inhibitors in the treatment of recurrent/metastatic (R/M) NPC. Both EBV-targeting and non-EBV-targeting immunotherapeutic strategies have been evaluated in early phase clinical trials over the last two decades. Several phase II studies have report